BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 26625774)

  • 1. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
    Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
    Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
    Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
    J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
    Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
    Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
    Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
    Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
    Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
    Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
    J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
    Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
    Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer].
    Wang XH; Qian YM; Miao L; Le Y; Du J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1003-5. PubMed ID: 27453113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D; Weiss G; Lack B; Chen V; Fusco J
    Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
    Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
    Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
    Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.